CoChat

Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability

Open access
Hendriks, Delilah F. G., Fredriksson Puigvert, Lisa, Messner, Simon, Mortiz, Wolfgang, Ingelman-Sundberg, Magnus · 2016 · Scientific Reports

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Drug-induced cholestasis (DIC) is poorly understood and its preclinical prediction is mainly limited to assessing the compound’s potential to inhibit the bile salt export pump (BSEP). Here, we evaluated two 3D spheroid models, one from primary human hepatocytes (PHH) and one from HepaRG cells, for the detection of compounds with cholestatic liability. By repeatedly co-exposing both models to a set of compounds with different mechanisms of hepatotoxicity and a non-toxic concentrated bile acid (BA) mixture for 8 days we observed a selective synergistic toxicity of compounds known to cause cholestatic or mixed cholestatic/hepatocellular toxicity and the BA mixture compared to exposure to the compounds alone, a phenomenon that was more pronounced after extending the exposure time to 14 days. In contrast, no such synergism was observed after both 8 and 14 days of exposure to the BA mixture for compounds that cause non-cholestatic hepatotoxicity. Mechanisms behind the toxicity of the cholestatic compound chlorpromazine were accurately detected in both spheroid models, including intracellular BA accumulation, inhibition of ABCB11 expression and disruption of the F-actin cytoskeleton. Furthermore, the observed synergistic toxicity of chlorpromazine and BA was associated with increased oxidative stress and modulation of death receptor signalling. Combined, our results demonstrate that the hepatic spheroid models presented here can be used to detect and study compounds with cholestatic liability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep35434

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of PHH and HepaRG spheroids. (A) Morphology of PHH and HepaRG spheroids. (B,C) Immunohistochemical analysis for MRP2 and BSEP protein expression in PHH and HepaRG spheroids at day 16 and 13 respectively with or without 8 day exposure to a mixture of BAs. Quantification of the surface expression of the BA transporters was performed using CellProfiler software. *p < 0.05. All scale bars = 100 μm.
Figure 1 Characterization of PHH and HepaRG spheroids. (A) Morphology of PHH and HepaRG spheroids. (B,C) Immunohistochemical analysis for MRP2 and BSEP protein expression in PHH and HepaRG spheroids at day 16 and 13 respectively with or without 8 day exposure to a mixture of BAs. Quantification of the surface expression of the BA transporters was performed using CellProfiler software. *p < 0.05. All scale bars = 100 μm.CC BY · PubMed Central
Figure 2 Exposure to hepatotoxins in the presence of bile acids reveals a selective synergistic toxicity of compounds with known cholestatic liability and bile acids. PHH and HepaRG spheroids were repeatedly exposed to a set of compounds with known cholestatic liability (bosentan, chlorpromazine and troglitazone) and compounds with non-cholestatic hepatotoxicity patterns (acetaminophen and tetracycline) in the presence or absence of a non-toxic BA mixture for 8 days (A) and 14 days (B). Cellular ATP content was measured as a marker for viability. Each data point is the mean ± SEM viability of n = 4–6 spheroids. Data are representative of 3 independent experiments.
Figure 2 Exposure to hepatotoxins in the presence of bile acids reveals a selective synergistic toxicity of compounds with known cholestatic liability and bile acids. PHH and HepaRG spheroids were repeatedly exposed to a set of compounds with known cholestatic liability (bosentan, chlorpromazine and troglitazone) and compounds with non-cholestatic hepatotoxicity patterns (acetaminophen and tetracycline) in the presence or absence of a non-toxic BA mixture for 8 days (A) and 14 days (B). Cellular ATP content was measured as a marker for viability. Each data point is the mean ± SEM viability of n = 4–6 spheroids. Data are representative of 3 independent experiments.CC BY · PubMed Central
Figure 3 Cholestatic risk classification of the tested hepatotoxins based on the cholestatic index (CIx). (A,B) Classification of the cholestatic risk of the tested compounds in PHH and HepaRG spheroids after 8 and 14 days of repeated exposure as determined by the cholestatic index (CIx). Three independent experiments for each compound are presented. Viability was assessed by measuring the cellular ATP content. (C) CIx values of a panel of hepatotoxins determined in multi-donor PHH spheroids after 14 days of repeated exposure. Viability was assessed by measuring albumin secretion, which has similar sensitivity to measuring the cellular ATP content in terms of determining the CIx values (Supplementary Fig. S2). For all figures: green: CIx ≥ 0.80; red: CIx ≤ 0.80.
Figure 3 Cholestatic risk classification of the tested hepatotoxins based on the cholestatic index (CIx). (A,B) Classification of the cholestatic risk of the tested compounds in PHH and HepaRG spheroids after 8 and 14 days of repeated exposure as determined by the cholestatic index (CIx). Three independent experiments for each compound are presented. Viability was assessed by measuring the cellular ATP content. (C) CIx values of a panel of hepatotoxins determined in multi-donor PHH spheroids after 14 days of repeated exposure. Viability was assessed by measuring albumin secretion, which has similar sensitivity to measuring the cellular ATP content in terms of determining the CIx values (Supplementary Fig. S2). For all figures: green: CIx ≥ 0.80; red: CIx ≤ 0.80.CC BY · PubMed Central
Figure 4 Mechanisms of chlorpromazine-induced cholestasis are recapitulated in PHH and HepaRG spheroids. PHH and HepaRG spheroids were repeatedly exposed to the model cholestatic compound chlorpromazine (CPZ) for 8 days. (A) BA accumulation was assessed by using the fluorescently labelled taurocholic acid derivative tauro-nor-THCA-24-DBD. Note that 10 μM CPZ was toxic to the HepaRG spheroids. (B) Expression of ABCB11, encoding BSEP, was analysed by RT-qPCR and normalized to the expression of the housekeeping gene GAPDH. Data represent the means ± SEM of 3 independent experiments. **p < 0.01. (C) F-actin cytoskeleton integrity was visualized by Phalloidin staining. All scale bars = 100 μm.
Figure 4 Mechanisms of chlorpromazine-induced cholestasis are recapitulated in PHH and HepaRG spheroids. PHH and HepaRG spheroids were repeatedly exposed to the model cholestatic compound chlorpromazine (CPZ) for 8 days. (A) BA accumulation was assessed by using the fluorescently labelled taurocholic acid derivative tauro-nor-THCA-24-DBD. Note that 10 μM CPZ was toxic to the HepaRG spheroids. (B) Expression of ABCB11, encoding BSEP, was analysed by RT-qPCR and normalized to the expression of the housekeeping gene GAPDH. Data represent the means ± SEM of 3 independent experiments. **p < 0.01. (C) F-actin cytoskeleton integrity was visualized by Phalloidin staining. All scale bars = 100 μm.CC BY · PubMed Central
Figure 5 Oxidative stress and modulation of death receptor signalling underlie the synergistic toxicity of chlorpromazine and bile acids. PHH and HepaRG spheroids were repeatedly exposed to chlorpromazine (CPZ) or acetaminophen (APAP) in the presence or absence of a non-toxic BA mixture. After 8 days, expression levels of the Nrf2 target gene SRXN1 (A), NFE2L2 (B) and DR5 (C) were evaluated by RT-qPCR and normalized to the expression of the housekeeping gene GAPDH. Data represent the means ± SEM of 3 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 5 Oxidative stress and modulation of death receptor signalling underlie the synergistic toxicity of chlorpromazine and bile acids. PHH and HepaRG spheroids were repeatedly exposed to chlorpromazine (CPZ) or acetaminophen (APAP) in the presence or absence of a non-toxic BA mixture. After 8 days, expression levels of the Nrf2 target gene SRXN1 (A), NFE2L2 (B) and DR5 (C) were evaluated by RT-qPCR and normalized to the expression of the housekeeping gene GAPDH. Data represent the means ± SEM of 3 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Figure 6 Working model for chlorpromazine-induced cholestatic toxicity. Chlorpromazine induces oxidative stress23, which is associated with the disruption of the F-actin cytoskeleton integrity, leading to intracellular BA accumulation. The oxidative stress is further synergistically enhanced by chlorpromazine and the accumulated BAs at toxic concentrations. In addition, chlorpromazine inhibits the expression of ABCB11, encoding BSEP, further aggravating BA accumulation. The accumulated toxic BAs induce DR5 expression, leading to the activation of the death receptor signalling pathway. Collectively, these events result in cell death.
Figure 6 Working model for chlorpromazine-induced cholestatic toxicity. Chlorpromazine induces oxidative stress23, which is associated with the disruption of the F-actin cytoskeleton integrity, leading to intracellular BA accumulation. The oxidative stress is further synergistically enhanced by chlorpromazine and the accumulated BAs at toxic concentrations. In addition, chlorpromazine inhibits the expression of ABCB11, encoding BSEP, further aggravating BA accumulation. The accumulated toxic BAs induce DR5 expression, leading to the activation of the death receptor signalling pathway. Collectively, these events result in cell death.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 156

Metadata

Authors
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M.
Affiliations
Karolinska Institutet (SE)
Venue
Scientific Reports
Published
2016-10-19
Volume
6
Issue
1
Pages
35434-35434
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2539243243
Cited by
156
References
51
Citations by year
2026: 8 · 2025: 14 · 2024: 12 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 26 · 2019: 23 · 2018: 18 · 2017: 10
FWCI
21.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Commission (115336, 267038)
  • Vetenskapsrådet (FP7/2007-2013)
  • Staatssekretariat für Bildung, Forschung und Innovation
  • Eurostars
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
drug-induced cholestasis, primary human hepatocytes, HepaRG cells, bile salt export pump, bile acids, synergistic toxicity, chlorpromazine, hepatotoxicity, ABCB11, F-actin cytoskeleton, oxidative stress, death receptor signaling
MeSH terms
Bile Acids and Salts, Biological Transport, Cell Line, Chlorpromazine, Cholestasis, Humans, Signal Transduction, Oxidative Stress, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Receptors, TNF-Related Apoptosis-Inducing Ligand, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. https://app.cochat.ai/papers/10.1038/srep35434
The paper
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016). Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Scientific Reports. https://doi.org/10.1038/srep35434

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.